Stay updated on ONCOS-102 Combo ImmunoTx in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the ONCOS-102 Combo ImmunoTx in Advanced Melanoma Clinical Trial page.

Latest updates to the ONCOS-102 Combo ImmunoTx in Advanced Melanoma Clinical Trial page
- CheckyesterdayChange DetectedThe record history now includes revision v3.3.4 and excludes revision v3.3.3, signaling an update to the study record.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page.SummaryDifference0.2%

- Check51 days agoChange DetectedRecord history now includes Revision v3.3.2 and no longer lists Revision v3.2.0.SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved the government funding/operating status banner from the page; the banner warned about potential delays in updates, but the core study information remains unchanged.SummaryDifference0.8%

- Check73 days agoChange DetectedNew and revised versions show updates to Study Identification, Study Status, Outcome Measures, Recruitment Status, and Study Design. These changes reflect updates to the trial’s core metadata, status, and Contacts/Locations.SummaryDifference0.1%

- Check101 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference13%

Stay in the know with updates to ONCOS-102 Combo ImmunoTx in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONCOS-102 Combo ImmunoTx in Advanced Melanoma Clinical Trial page.